It's official. Tesla Inc. (TSLA) is the most hated stock on the market.
Tesla has the highest short interest of any major company, the only stock in the top 10 with less than a $100 billion market capitalization. In other words, the huge short position in Tesla isn't just a conseque
Charles Schwab (NYSE:SCHW) had its price objective lowered by Credit Suisse Group from $69.00 to $60.00 in a research note published on Wednesday morning. The brokerage currently has an outperform rating on the financial services provider’s stock.
Other equities analysts have also issued reports about the company. Morgan Stanley increased their price target on Charles Schwab from $63.00....More>>>
Stocks fell the most since February as investors decided that maybe the market had come too far than justified by fundamentals.
Michael Nagle/Bloomberg News
The S&P 500 rose 1.2% to 2,041.91 today, its biggest decline since Feb. 23, while the Dow Jones Industrial Average fell 174.09 points, or 1%, to 17,541.96. The Nasdaq Composite tumbled 1.5% to4848.37, its biggest drop....More>>>
The Starbucks Corp. (SBUX) CEO, one year into his tenure, is in the midst of a full-blown public relations crisis. "Boycott Starbucks" continues to trend on Monday, April 16, four days after a Starbucks employee called the police on two black men in
European stocks edged higher on Friday, with the benchmark index scoring a third straight week of gains, as investors watched for developments in the Syria situation and in the trade spat between the U.S. and China.
European markets had traded with sizable gains earlier in the session,
Oil prices were falling back Thursday off three-year highs hit in the prior trading session amid political tensions in the Middle East, but analysts are generally optimistic about stocks in the space, meaning Thursday's dip could represent a buying opportunity.
U.S. stock-index futures pointed to a modestly higher open on Tuesday, though caution and volatility were expected to remain elevated after a broad selloff in the previous session took the S&P 500 below a key technical level and erased the Nasdaqs gains for the year.
WuXi AppTec announced a $910 million IPO on the Shanghai exchange for the company's core small-molecule CRO business. China regulators approved WuXi's prospectus in a short seven weeks, indicating that they are very eager to list the company, China's largest CRO, on a domest